Asked by: Samantha Niblett (Labour - South Derbyshire)
Question to the Department of Health and Social Care:
To ask the Secretary of State for Health and Social Care, what vetting procedures are in place to ensure care agencies providing non UK workers in the care industry ensure the safety of patients before allowing workers to commence a caring role.
Answered by Stephen Kinnock - Minister of State (Department of Health and Social Care)
Care agencies who carry out a regulated activity must be registered by the Care Quality Commission (CQC) and are expected to comply with relevant regulations. Where a care agency does not carry out a regulated activity but supplies workers to a regulated care provider, the legal duty to comply with CQC regulations sits with the registered provider using the agency and the registered manager.
Regulation 19 of the Health and Social Care Act 2008 (Regulated Activities) Regulations 2014 sets out that it is the responsibility of the regulated provider to ensure robust and safe recruitment practices are in place, and to make sure that all staff, including agency staff, are suitably experienced, competent, and able to carry out their role. Further information on Regulation 19 is avaiable at the following link:
Registered providers are also expected to comply with Regulation 18: Staffing, which sets out a provider’s responsibility to deploy enough suitably qualified, competent, and experienced staff. Further information on Regulation 18 is avaiable at the following link:
The CQC can assess compliance with these regulations through assessment and monitoring activity. Where a breach of regulation or non-compliance is identified, the CQC can take regulatory action.
An Enhanced Disclosure and Barring Service (DBS) check must be undertaken prior to the recruitment of all care workers. In line with the CQC guidance for DBS checks, staff working with vulnerable adults can only start work before a DBS certificate is received if they have had a DBS Adult First Check, are appropriately supervised, and do not escort people away from the premises unless accompanied by someone with a DBS check.
Asked by: Samantha Niblett (Labour - South Derbyshire)
Question to the Department of Health and Social Care:
To ask the Secretary of State for Health and Social Care, whether he has had discussions with NICE on its Final Draft Guidance which does not recommend CAR-T therapy for relapsed or refractory Mantle Cell Lymphoma.
Answered by Zubir Ahmed - Parliamentary Under-Secretary (Department of Health and Social Care)
Department officials regularly discuss a range of issues with colleagues in the National Institute for Health and Care Excellence (NICE), including in relation to the development of guidance on individual products.
NICE develops its recommendations on new medicines independently on the basis of a thorough assessment of the available evidence and through extensive engagement with interested parties. NICE is currently re-evaluating the CAR-T therapy brexucabtagene autoleucel (Tecartus) to determine whether it can be recommended for routine National Health Service use, taking into account real-world evidence generated through its use in the Cancer Drugs Fund.
Asked by: Samantha Niblett (Labour - South Derbyshire)
Question to the Department of Health and Social Care:
To ask the Secretary of State for Health and Social Care, what consideration his department has made of the potential merits of providing parity in pay and conditions between primary care nursing staff and their Agenda for Change colleagues in the NHS.
Answered by Stephen Kinnock - Minister of State (Department of Health and Social Care)
The Government is committed to ensuring the general practice nursing workforce is sustainable, supported and valued for the work they do.
The Government looks to the independent pay review bodies for a pay recommendation for National Health Service staff, including both contractor and salaried general practitioners (GPs). They consider a range of evidence from organisations including the Government, the NHS and trade unions to reach their recommendations.
The independent review body on Doctors’ and Dentists’ Remuneration (DDRB) recommended an uplift of 4% to the pay ranges for salaried GPs, and to GP contractor pay. As with the previous year, we accepted the DDRB’s pay recommendation. We provided an increase to core funding for practices to allow this 4% pay uplift, on top of the provisional 2.8% uplift already provided, to be passed on to salaried and contractor GPs. The additional funding also allows for pay uplifts for other salaried general practice staff, including nurses. We expect GP contractors to implement pay rises to other practice staff in line with the uplift in funding they have received.
As self-employed contractors to the NHS, it is up to general practices how they distribute pay and benefits to general practice nurses and other staff. General practice contractual arrangements do not place any specific obligations on practices regarding general practice nurse terms and conditions.
We are investing an additional £1.1 billion in general practice to reinforce the front door of the NHS, bringing total spend on the GP Contract to £13.4 billion in 2025/26, representing the biggest cash increase in over a decade. The 8.9% boost to the GP contract in 2025/26 is greater than the 5.8% growth to the NHS budget overall.
Asked by: Samantha Niblett (Labour - South Derbyshire)
Question to the Department of Health and Social Care:
To ask the Secretary of State for Health and Social Care, pursuant to the Answer of 11 December 2025 to Question 97018, what proportion of his Department expenditure on Microsoft Software licenses and services was allocated to (a) new service implementations and (b) renewal or maintenance of existing system; and how this compares to the previous year’s expenditure in each category.
Answered by Karin Smyth - Minister of State (Department of Health and Social Care)
The following table shows the information requested:
Year | New Service Implementations | Renewal and Maintenance of existing Systems |
4 December 2024 – 5 December 2025 | 15.2% | 84.8% |
4 December 2023 – 5 December 2024 | 0% | 100% |
Source: Department of Health and Social Care
Asked by: Samantha Niblett (Labour - South Derbyshire)
Question to the Department of Health and Social Care:
To ask the Secretary of State for Health and Social Care, what proportion of spending on Microsoft software licenses and services between (a) 4 December 2024 and 5 December 2025 and (b) 4 December 2023 and 5 December 2024 was allocated to (i) new service implementations and (ii) renewal and maintenance of existing systems.
Answered by Karin Smyth - Minister of State (Department of Health and Social Care)
The following table shows the proportion of spending on Microsoft software licenses and services between 4 December 2024 and 5 December 2025, and between 4 December 2023 and 5 December 2024 that was allocated to new service implementations and renewal, and to the maintenance of existing systems:
Period | New service implementations | Renewal and maintenance of existing systems |
4 December 2024 to 5 December 2025 | 15.2% | 84.8% |
4 December 2023 to 5 December 2024 | 0% | 100% |
Asked by: Samantha Niblett (Labour - South Derbyshire)
Question to the Department of Health and Social Care:
To ask the Secretary of State for Health and Social Care, how much his Department has spent on software licences from Microsoft in the last 12 months; and what proportion this represents of his Department’s total technology spend.
Answered by Karin Smyth - Minister of State (Department of Health and Social Care)
For the period 4 December 2024 to 5 December 2025, the Department spent £4.8 million on Microsoft Software licenses and services. During this period this spend accounted for 25.2% of the overall internal technology spend.
Asked by: Samantha Niblett (Labour - South Derbyshire)
Question to the Department of Health and Social Care:
To ask the Secretary of State for Health and Social Care, for what reason older people under 75 are not eligible for the NHS covid-19 autumn booster in 2025.
Answered by Ashley Dalton - Parliamentary Under-Secretary (Department of Health and Social Care)
The Joint Committee on Vaccination and Immunisation (JCVI) is an independent expert committee which reviews the latest data on COVID-19 risks, vaccine safety, and effectiveness and advises the department on the approach to vaccination and immunisation programmes. The JCVI has published advice for future COVID-19 vaccination campaigns in autumn 2025, spring 2026, autumn 2026, and spring 2027. The Government has accepted JCVI advice for autumn 2025. The Government is considering the JCVI’s advice for 2026 and spring 2027 carefully and will respond in due course.
The primary aim of the national COVID-19 vaccination programme remains the prevention of serious disease (hospitalisations and deaths) arising from COVID-19. The JCVI assessment indicates that the oldest age cohorts and individuals who are immunosuppressed are the two groups who continue to be at higher risk of serious disease.
Therefore, in autumn 2025, a COVID-19 vaccination will be offered to:
Asked by: Samantha Niblett (Labour - South Derbyshire)
Question to the Department of Health and Social Care:
To ask the Secretary of State for Health and Social Care, whether his Department has made an assessment of the potential impact of sites previously used to dump fly ash now used for house building on public health.
Answered by Ashley Dalton - Parliamentary Under-Secretary (Department of Health and Social Care)
The UK Health Security Agency (UKHSA) has not undertaken any overarching assessment of the potential impact on public health from housebuilding on sites previously used to deposit fly ash.
Assessments of potential land contamination used for housing are governed at national level by the Department for Environment, Food & Rural Affairs under contaminated land legislation and the Ministry of Housing, Communities and Local Government under planning legislation. Local authorities assess land within their areas with respect to contaminated land, and Local Planning Authorities address legacy contamination through local plans and development management.
In England and Wales, local authorities are required to assess their areas to identify and remove unacceptable risks to public health and the environment, and act as a regulator to ensure that contaminated land is made suitable for its current use. Specific development sites brought into use for housing should be adequately risk-assessed, and any required remediation overseen, within the planning process.
Asked by: Samantha Niblett (Labour - South Derbyshire)
Question to the Department of Health and Social Care:
To ask the Secretary of State for Health and Social Care, what steps his Department is taking to (a) ensure nursing graduates can find Band 5 roles upon graduation and (b) increase the number of roles for newly registered nurses.
Answered by Karin Smyth - Minister of State (Department of Health and Social Care)
On 11 August 2025, the Government announced the Graduate Guarantee for nurses and midwives. The Guarantee will ensure there are enough positions for every newly qualified nurse in England. The package of measures will unlock thousands of jobs and will ensure thousands of new posts are easier to access by removing barriers for National Health Service trusts, creating opportunities for graduates and ensuring a seamless transition from training to employment.